more_reports

The Latest Regenerative Medicine Articles from Streetwise Reports

Life Sciences Co. Reports Strong Survival Data

Research Report
  ()
OS Therapies Inc.'s (OSTX:NYSEAMERICAN) trial results are for its new immunotherapy in fully resected pulmonary metastatic osteosarcoma, noted a D. Boral Capital report.
Tags: Regenerative Medicine

Showing Results: 1 to 1 of 1